Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol

Clioquinol has been shown to have anticancer activity in several carcinoma cells. In this study, we preliminarily examined the effect of clioquinol in human SMMC-7721 hepatoma and QSG-7701 normal hepatic cells. Our results indicated that clioquinol did not significantly affect survival of QSG-7701 c...

Full description

Saved in:
Bibliographic Details
Main Authors: Huang Zhiwei, Wang Lianqiu, Chen Lifeng, Zhang Yifei, Shi Ping
Format: Article
Language:English
Published: Sciendo 2015-12-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.1515/acph-2015-0034
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572506615054336
author Huang Zhiwei
Wang Lianqiu
Chen Lifeng
Zhang Yifei
Shi Ping
author_facet Huang Zhiwei
Wang Lianqiu
Chen Lifeng
Zhang Yifei
Shi Ping
author_sort Huang Zhiwei
collection DOAJ
description Clioquinol has been shown to have anticancer activity in several carcinoma cells. In this study, we preliminarily examined the effect of clioquinol in human SMMC-7721 hepatoma and QSG-7701 normal hepatic cells. Our results indicated that clioquinol did not significantly affect survival of QSG-7701 cells, whereas it reduced cell viability in a concentration- and time-dependent manner in SMMC-7721 cells. Clioquinol did not trigger autophagy and apoptosis, while it induced cell cycle arrest in the S-phase in SMMC- 7721 cells. Additionally, down-regulation of cyclin D1, A2, E1, Cdk2 and up-regulation of p21, p27 were detected after the treatment with clioquinol. The results demonstrated for the first time that clioquinol suppressed cell cycle progression in the S-phase in SMMC-7721 cells via the p21, p27-cyclin E,A/Cdk2 pathway. This suggests that clioquinol may have a therapeutic potential as an anticancer drug for certain malignances.
format Article
id doaj-art-c366976cf2e3476db1225bea27e81b41
institution Kabale University
issn 1846-9558
language English
publishDate 2015-12-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-c366976cf2e3476db1225bea27e81b412025-02-02T09:57:48ZengSciendoActa Pharmaceutica1846-95582015-12-0165446347110.1515/acph-2015-0034acph-2015-0034Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinolHuang Zhiwei0Wang Lianqiu1Chen Lifeng2Zhang Yifei3Shi Ping4Key Lab of Eco-Textile (Ministry of Education), College of Chemistry Chemical Engineering and Biotechnology Donghua University Shanghai 201620, ChinaKey Lab of Eco-Textile (Ministry of Education), College of Chemistry Chemical Engineering and Biotechnology Donghua University Shanghai 201620, ChinaKey Lab of Eco-Textile (Ministry of Education), College of Chemistry Chemical Engineering and Biotechnology Donghua University Shanghai 201620, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology Shanghai 200237, ChinaState Key Laboratory of Bioreactor Engineering, East China University of Science and Technology Shanghai 200237, ChinaClioquinol has been shown to have anticancer activity in several carcinoma cells. In this study, we preliminarily examined the effect of clioquinol in human SMMC-7721 hepatoma and QSG-7701 normal hepatic cells. Our results indicated that clioquinol did not significantly affect survival of QSG-7701 cells, whereas it reduced cell viability in a concentration- and time-dependent manner in SMMC-7721 cells. Clioquinol did not trigger autophagy and apoptosis, while it induced cell cycle arrest in the S-phase in SMMC- 7721 cells. Additionally, down-regulation of cyclin D1, A2, E1, Cdk2 and up-regulation of p21, p27 were detected after the treatment with clioquinol. The results demonstrated for the first time that clioquinol suppressed cell cycle progression in the S-phase in SMMC-7721 cells via the p21, p27-cyclin E,A/Cdk2 pathway. This suggests that clioquinol may have a therapeutic potential as an anticancer drug for certain malignances.https://doi.org/10.1515/acph-2015-0034clioquinolhuman smmc-7721 hepatoma cellscell cycle s-phase arrestcyclin e/a-cdk2
spellingShingle Huang Zhiwei
Wang Lianqiu
Chen Lifeng
Zhang Yifei
Shi Ping
Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
Acta Pharmaceutica
clioquinol
human smmc-7721 hepatoma cells
cell cycle s-phase arrest
cyclin e/a-cdk2
title Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
title_full Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
title_fullStr Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
title_full_unstemmed Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
title_short Induction of cell cycle arrest via the p21, p27–cyclin E,A/Cdk2 pathway in SMMC-7721 hepatoma cells by clioquinol
title_sort induction of cell cycle arrest via the p21 p27 cyclin e a cdk2 pathway in smmc 7721 hepatoma cells by clioquinol
topic clioquinol
human smmc-7721 hepatoma cells
cell cycle s-phase arrest
cyclin e/a-cdk2
url https://doi.org/10.1515/acph-2015-0034
work_keys_str_mv AT huangzhiwei inductionofcellcyclearrestviathep21p27cyclineacdk2pathwayinsmmc7721hepatomacellsbyclioquinol
AT wanglianqiu inductionofcellcyclearrestviathep21p27cyclineacdk2pathwayinsmmc7721hepatomacellsbyclioquinol
AT chenlifeng inductionofcellcyclearrestviathep21p27cyclineacdk2pathwayinsmmc7721hepatomacellsbyclioquinol
AT zhangyifei inductionofcellcyclearrestviathep21p27cyclineacdk2pathwayinsmmc7721hepatomacellsbyclioquinol
AT shiping inductionofcellcyclearrestviathep21p27cyclineacdk2pathwayinsmmc7721hepatomacellsbyclioquinol